Samsung Medical Center
Seoul, South Korea
NCT Number: NCT05193539
The purpose of this study was to assess the efficacy of augmented and virtual reality-based rehabilitation programs on improving upper extremity function in subacute stroke patients.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Seoul, South Korea
This was a randomized, single-blinded study, conducted at a single acute rehabilitation unit in a university hospital. In this study, the effect of augmented and virtual reality-based rehabilitation for the recovery of subacute stroke patients compared with conventional occupational therapy was evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group underwent augmented reality and virtual reality rehabilitation with 4 different systems.
The RAPAEL Smart Glove® is a wearable sensory system that contains a single 9-axis movement and position sensor with 3 acceleration channels, 3 angular rate channels, and 3 magnetic field channels that measures wrist movements, and 5 bending sensors that measure finger movements. The RAPAEL Smart Board® is a rehabilitation system used to improve arm function by practicing gravity-compensated movements. The RehabMaster® is a game-based Kinect sensor AR rehabilitation system which uses a 3D camera to digitize patient movements and quickly analyze their range of motion, speed, motion angle, and movement cycles. rehabilitation exercise using games to encourage active arm and trunk movements and promote successful rehabilitation. The COG-Trainer® is a VR system that uses a training device synchronized with the screen through simulation.
The group underwent standard ocupational therapy, such as range of motion and strengthening exercises for the affected upper extremity, table-top activities, and training for activities of daily living.
Time frame: Baseline
range (0-126), higher scores mean a better motor function
Time frame: 2 weeks after intervention
range (0-126), higher scores mean a better motor function
Time frame: Baseline
higher scores mean a worse motor function
Time frame: 2 weeks after intervention
higher scores mean a worse motor function
Time frame: Baseline
range (0-100), higher scores mean a better activity of daily living
Time frame: 2 weeks after intervention
range (0-100), higher scores mean a better activity of daily living
Time frame: Baseline
range (0-150), higher scores mean a better activity of daily living
Time frame: 2 weeks after intervention
range (0-150), higher scores mean a better activity of daily living
Time frame: Baseline
range (0-100), higher scores mean a better quality of life
Time frame: 2 weeks after intervention
range (0-100), higher scores mean a better quality of life
Time frame: Baseline
range (0-56), higher scores mean a better balance function
Time frame: 2 weeks after intervention
range (0-56), higher scores mean a better balance function
Time frame: Baseline
higher scores mean a better hand function
Time frame: 2 weeks after intervention
higher scores mean a better hand function
Time frame: Baseline
higher scores mean a worse hand function
Time frame: 2 weeks after intervention
higher scores mean a worse hand function
Samsung Medical Center
Other
Effects of Comprehensive Augmented and Virtual Reality for Upper Limb Rehabilitation in First-Ever Stroke Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details